Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M53.7Revenue $M0.8Net Margin (%)-7,960.3Z-Score-11.0
Enterprise Value $M11.5EPS $-2.9Operating Margin %-7,968.0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-7,972.0Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %0Quick Ratio4.6Cash flow > EarningsN
Price/Sales67.05-y EBITDA Growth Rate %0Current Ratio4.6Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-84.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-126.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M21.7ROI % (ttm)-164.1Gross Margin Increase y-yN

Gurus Latest Trades with ONTX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ONTXGeorge Soros 2014-09-30 Sold Out $4.325 - $5.64
($5.07)
$ 2.47-105%Sold Out0
ONTXGeorge Soros 2014-06-30 Buy $4.18 - $6.22
($5.24)
$ 2.47-112%New holding10,774
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ONTX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ONTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hoffman Michael BDirector, 10% Owner 2014-02-21Buy143,480$8.47-72.61 view
Michael & Jane Hoffman 2013 De10% Owner 2014-02-21Buy143,480$8.47-72.61 view
Kumar RameshPresident and CEO 2014-02-10Sell33,543$15.07-84.61 view
Kumar RameshPresident and CEO 2014-02-03Sell60,000$15.05-84.58 view
Michael & Jane Hoffman 2013 De10% Owner 2014-01-27Buy57,295$11.92-80.54 view
Hoffman Michael BDirector, 10% Owner 2014-01-27Buy57,295$11.92-80.54 view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-22Buy5,000$14.39-83.88 view
Hoffman Michael BDirector, 10% Owner 2013-11-22Buy5,000$14.39-83.88 view
Michael & Jane Hoffman 2013 De10% Owner 2013-11-18Buy5,000$11.87-80.45 view
Hoffman Michael BDirector, 10% Owner 2013-11-18Buy5,000$11.87-80.45 view

Press Releases about ONTX :

    Quarterly/Annual Reports about ONTX:

    News about ONTX:

    Articles On GuruFocus.com
    Weekly 3-Year Low Highlights: VCRA, CLUB, ARGS, ONTX, BOTA Jun 08 2014 

    More From Other Websites
    Onconova Therapeutics, Inc. to Present New Data on Rigosertib and Earlier-Stage Programs at the 2015... Apr 07 2015
    Onconova Therapeutics, Inc. to Present New Data on Rigosertib and Earlier-Stage Programs at the 2015... Apr 07 2015
    ONCONOVA THERAPEUTICS, INC. Financials Apr 03 2015
    ONCONOVA THERAPEUTICS, INC. Files SEC form 10-K, Annual Report Mar 30 2015
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 27 2015
    Onconova reports 4Q loss Mar 26 2015
    Onconova reports 4Q loss Mar 26 2015
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and Fourth Quarter and Year-End 2014... Mar 26 2015
    Onconova Therapeutics, Inc. Reports Recent Business Highlights and Fourth Quarter and Year-End 2014... Mar 26 2015
    Biotech IPO Performance: Discerning Market Or Rising Tide? Mar 20 2015
    Onconova Therapeutics, Inc. (ONTX) Rises: Stock Up 11.4% - Tale of the Tape Mar 18 2015
    Onconova Therapeutics, Inc. to Present at 27th Annual ROTH Conference Mar 04 2015
    Onconova Therapeutics, Inc. to Present at 27th Annual ROTH Conference Mar 04 2015
    Onconova Therapeutics (ONTX) Enters Oversold Territory - Tale of the Tape Feb 04 2015
    Onconova Announces Clinical Development Plan for Rigosertib in Higher Risk Myelodysplastic Syndrome... Feb 02 2015
    Onconova Therapeutics, Inc. to Present at Upcoming Investor Conferences in February Jan 30 2015
    Onconova Therapeutics, Inc. to Present at Upcoming Investor Conferences in February Jan 30 2015
    Onconova Therapeutics Appoints Dr. Steven M. Fruchtman as Chief Medical Officer Jan 12 2015
    ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 10 2014
    Onconova Announces ONTIME Data Presentations at the 2014 ASH Annual Meeting Dec 07 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK